EDAP TMS S.A. (EDAP)
NASDAQ: EDAP
· Real-Time Price · USD
2.15
0.03 (1.42%)
At close: May 01, 2025, 3:01 PM
1.42% (1D)
| Bid | 2.13 |
| Market Cap | 80.39M |
| Revenue (ttm) | 64.2M |
| Net Income (ttm) | -19.04M |
| EPS (ttm) | -0.58 |
| PE Ratio (ttm) | -3.71 |
| Forward PE | -5.02 |
| Analyst | Buy |
| Ask | 2.19 |
| Volume | 27,877 |
| Avg. Volume (20D) | 124,170 |
| Open | 2.15 |
| Previous Close | 2.12 |
| Day's Range | 2.05 - 2.15 |
| 52-Week Range | 1.26 - 7.40 |
| Beta | 0.13 |
About EDAP
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and ma...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 1, 1997
Employees 310
Stock Exchange NASDAQ
Ticker Symbol EDAP
Website https://www.edap-tms.com
Analyst Forecast
According to 3 analyst ratings, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 109.30% from the latest price.
Stock Forecasts2 days ago
-3.21%
EDAP stock has given up its prior gain. EDAP TMS s...
Unlock content with
Pro Subscription
2 days ago
-3.21%
EDAP TMS shares are trading higher after the company announced the FARP study achieved its primary endpoint.
